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Dental caries is one of the most widely prevalent infectious diseases in the world. It affects
more than half of the world’s population. The current treatment for necrotic dental pulp
tissue arising from dental caries is root canal therapy. This treatment results in loss of tooth
sensitivity and vitality making it prone for secondary infections. Over the past decade,
several tissue-engineering approaches have attempted regeneration of the dental pulp
tissue. Although several studies have highlighted the potential of dental stem cells, none
have transitioned into a clinical setting owing to limited availability of dental stem cells and
the need for growth factor delivery systems. Our strategy is to utilize the intact ECM of
pulp cells to drive lineage specific differentiation of bone marrow derived mesenchymal
stem cells. From a clinical perspective, pulp ECM scaffolds can be generated using
cell lines and patient specific somatic stem cells can be used for regeneration. Our
published results have shown the feasibility of using pulp ECM scaffolds for odontogenic
differentiation of non-dental mesenchymal cells. This focused review discusses the issues
surrounding dental pulp tissue regeneration and the potential of our strategy to overcome
these issues.
Keywords: biomimetics, extracellular matrix, collagen, chitosan, dental pulp regeneration, dental pulp stem cells,
bone marrow stem cells
Introduction
Tissue engineering of dental and craniofacial tissues has gained enormous prominence in the past
decade. In spite of these advances, clinical translation has remained elusive. One of the primary rea-
sons lies in the specialized nature of dental tissue cell types and the limited availability of somatic
stem cells that can be used to regenerate these tissues.
As proposed more than two decades ago by Langer and Vacanti, tissue engineering requires
a triad of cells, scaffolds and growth factors (Langer and Vacanti, 1993). However, the approach
toward maximizing the potential of this triad has been evolving consistently. In this focused review,
we will discuss our biomimetic approach aimed at regeneration of dental pulp tissue. Additionally,
we will also discuss the potential of this technology for regeneration of other tissues.
Dental Caries and Pulp Tissue
Dental caries is one of the most prevalent infectious disease in the world second only
to the common cold (Islam et al., 2007). In the United States, it is the most widely
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prevalent infectious disease. A world health organization (WHO) report states that approximately
90% of the world’s population has experienced dental caries. Poor oral hygiene is the primary cause
for caries. However, several medical treatments such as radiation therapy and chemotherapy can
also cause caries. Additionally, the use of drugs that negatively affect salivation can also result
in caries. The disease is characterized by bacterial infection of the teeth. The pathogenic bacte-
ria generate an acidic environment that slowly degrades the enamel and dentin hydroxyapatite
and eventually exposes the dental pulp tissue for infection. Dental caries in its advanced stage is
characterized by infected necrotic dental pulp tissue.
The dental pulp tissue is a highly vascularized and innervated specialized soft tissue that pro-
vides vitality to the tooth. The functions of dental pulp tissue range from response to bacterial
insult and injury to transmission of mechanical stimuli and promotion of regeneration. However,
the tissue itself possesses limited regenerative potential due to its anatomical arrangement and the
specialized nature of dental pulp and odontoblast cells.
KEY CONCEPT 1 | Dental pulp and caries
Dental pulp is a highly vascularized and innervated soft tissue that fills the root canal space. This soft tissue provides vitality
to the tooth by serving as a mechano transducer of physical stimulus, by providing regenerative ability to form reparative
dentin resulting from minor insult or injury and also by providing immediate response to bacterial insult. Dental caries is
caused by bacterial infection of the dental pulp tissue leading to necrotic pulp tissue. It occurs primarily due to lack of oral
hygiene, but can also be a result of several medical treatments such as chemotherapy.
Root Canal Therapy
The current treatment for infected necrotic pulp is root canal therapy. Root canal therapy involves
removal of the infected pulp tissue, disinfection of the pulp chamber, and filling of the chamber with
gutta percha, a synthetic compound devoid of ability to support or promote regeneration of living
tissue. As a result, the tooth loses its sensitivity and vitality and becomes a dead tooth. Therefore,
teeth subjected to root canal therapy cannot respond immunologically to subsequent infections.
Although the root canal space is disinfected prior to therapy, as a result of immunological inertness,
subsequent secondary infections arising due to lack of oral hygiene or other continuing causes may
go unnoticed until they spread to neighboring tissues resulting in a chronic condition that signifi-
cantly affects the quality of life. In some rare cases, this might lead to loss of life as a result of sepsis.
KEY CONCEPT 2 | Root canal therapy
This is the current treatment for necrotic pulp tissue. This treatment is characterized by removal of the necrotic pulp tissue,
disinfection of the root canal space and filling up the pulp chamber with an inorganic compound followed by capping.
In children and adolescents with immature permanent teeth, root canal therapy poses an even
greater problem by preventing root maturation. The result is loos of tooth due to cervical root
fracture. This type of failure is the leading cause for treatment failure in immature teeth (Cvek,
1992). In order to preserve the vitality of the tooth in adults and to promote normal root matura-
tion and longevity of immature permanent teeth in children, a regenerative strategy is required as
a replacement for root canal therapy.
Current Approaches to Dental Pulp Tissue Regeneration
The drawbacks of root canal therapy in adults and children can be overcome if regeneration of
functional pulp tissue can be accomplished clinically. An appropriate stem cell source is required
to accomplish this task successfully. Dental pulp stem cells (DPSCs) are currently the preferred
cell type for dental pulp tissue regeneration. DPSCs are mesenchymal stem cells that reside within
the pulp tissue and are capable of multi-lineage differentiation (Shi et al., 2001; Shi and Gronthos,
2003; Kerkis et al., 2006; Huang et al., 2009). Other stem cell sources for pulp tissue engineering
include stem cells from exfoliated deciduous teeth (SHED), stem cells from apical papilla (SCAP),
and periodontal ligament derived stem cells (PDLSCs).
Dental pulp tissue engineering has been investigated in vivo in small animal models
using DPSCs (Gronthos et al., 2002; Demarco et al., 2010; Karaoz et al., 2011), SHED
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(Cordeiro et al., 2008; Rosa et al., 2013), SCAP (Huang et al.,
2010), and PDLSCs (Ravindran et al., 2014a, 2012b) and a variety
of growth factors that includes fibroblast growth factors (FGFs)
(Morito et al., 2009) and bone morphogenetic proteins (BMPs)
(Nakashima, 1994; Nakashima and Reddi, 2003).
Recently, dental pulp tissue engineering was attempted in a
canine pulpectomy model in mature (Iohara et al., 2011) and
immature teeth (Wang et al., 2013). The studies were performed
using a side population of DPSCs (CD105 +ve cells) and stro-
mal derived factor 1 (SDF1) was used as the growth factor of
choice to induce functional pulp tissue regeneration including
vascularization and innervation. Additionally, DPSCs when used
in conjunction with granulocyte stimulating factor (GSF) to iso-
late a side population of cells exhibiting higher mobility, showed
an improved regenerative potential. Additionally, no change was
observed in regenerative potential with cells isolated from aged
dogs or regeneration in aged dogs in general when this combina-
tion was used (Iohara et al., 2013; Nakashima and Iohara, 2014).
However, the caveat, as acknowledged by the authors, is that the
clinical translation of the research is limited by the availability of
viable autologous dental pulps.
Additionally, DPSCs have also been used to regenerate bone.
Recent studies in human graft models show the potential of
autologous DPSCs to regenerate bone in a clinical setting. This
study provides a valuable insight into the use of DPSCs clinically
(D’aquino et al., 2009).
Limitations of Dental Stem Cells
Dental stem cells are the ideal cell types for regeneration of den-
tal tissues. However, the primary drawback associated with all of
the dental stem cells mentioned above is their limited availability
(Feng and Lengner, 2013). The easiest and most accessible way
of isolating DPSCs is from the extracted third molars of patients
(Tirino et al., 2012). However, in many cases, the third molars
are infected or removed as a result of caries. Additionally, the
number of cells obtained will not be sufficient to treat multiple
carious teeth or to treat any teeth that may be infected in the
future. On the other hand, DPSCs are also available for isolation
from the inflamed pulp tissues (Alongi et al., 2010). These cells
possess similar potential compared to DPSCs from natural pulp,
albeit slightly altered stem cell characteristics. If successful, this
technique can prove to be quite valuable. However, the success
depends on the quality of the inflamed pulp and also the amount
of cells that can be isolated from it.
SHED are stem cells that need to be isolated from decid-
uous teeth. However, their effectiveness in clinical therapy is
heavily dependent upon development of reliable stem cell bank-
ing technologies. Even if such technologies are developed the
procedure may not be cost effective for most of the popu-
lation as a viable option for treatment of caries. Moreover,
as the cells need to be autologous, a majority of the current
adult population will not be able to avail the benefits of this
technology.
Finally, SCAP are stem cells that are isolated from develop-
ing teeth. Therefore, it is highly improbable that they can serve as
viable source for stem cells from a clinical perspective.
Limitations of Growth Factor Delivery
Systems
Current approaches to pulp tissue engineering and regenerative
medicine in general focus on the use of growth factor delivery
systems to deliver one or more growth factors to induce lineage
specific differentiation of stem cells. Several natural and poly-
meric growth factor delivery systems have been developed for
controlled delivery of growth factors (Vo et al., 2012). However,
the timing of delivery, long-term stability and dosage of these
growth factors limit the translational potential severely. Another
important consideration is that in vivo, the stem cells use sev-
eral different growth factors at different stages of differentiation
and in unique combinations to achieve and maintain lineage spe-
cific differentiation. Therefore, it is not realistic to expect that a
single growth factor or a handful of growth factors can generate
the same effect as the complete extracellular environment that the
cells perceive in vivo.
Alternative Stem Cell Sources
With the limited availability of dental stem cells, the need for
exploring other stem cell sources for clinical translation is high.
Published studies have shown that stem cells isolated from the
bonemarrow, adipose tissue, and placenta have similar epigenetic
profiles (Aranda et al., 2009). However, in one study that com-
pared bone marrow derived mesenchymal stem cells (BMSCs)
and adipose tissue derived mesenchymal stem cells (ADMSCs)
for pulp tissue regeneration in a canine model, BMSCs were not
as potent as DPSCs or ADMSCs (Ishizaka et al., 2012). This study
required the use of growth factor delivery (SDF1) and a side pop-
ulation of CD31(−) cells. From a translational perspective, the
safety and dosage of SDF1 has not been established and to obtain
side populations of autologous stem cells is difficult. Therefore,
an efficient system that can direct lineage specific differentiation
of alternate stem cell sources that does not rely on growth factor
delivery is required.
The bone marrow is self-renewing and BMSCs have clini-
cally standardized isolation procedures and are relatively easy
to obtain compared to other stem cell sources. Although not
ideal for pulp tissue regeneration using conventional approaches,
translational feasibility is highest for BMSCs as opposed to dental
stem cells. Both DPSCs and BMSCs are of mesenchymal origin.
DPSCs are derived from the neural crest and BMSCs from the
bone marrow. This fundamental difference in these two stem
cell types results in different behavioral characteristics (Shi et al.,
2001; Yu et al., 2007). However, if provided with appropriate
extracellular environment, our results indicate that BMSCs can
undergo odontogenic differentiation.
Another important consideration is the ability of BMSCs to
confer an innate ability to defend against infection. Several pub-
lished reports highlight the roles and importance of BMSCs
in modulating the maintenance and migration of hematopoi-
etic stem cells (HSCs) and monocyte emigration (Mendez-Ferrer
et al., 2010; Ehninger and Trumpp, 2011; Shi et al., 2011). As a
direct role-player in action against infection, BMSCs can actively
prolong survival during sepsis, reduce microbial growth, and
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burden post infection (Nemeth et al., 2009; Krasnodembskaya
et al., 2010; Mei et al., 2010; Meisel et al., 2011). Considering these
factors, BMSCs form the ideal source for clinically relevant pulp
tissue regeneration.
The Extracellular Matrix (ECM)
Living organisms are made up of tissues that consist of live cells
embedded within an ECM. The ECM constitutes framework
of structural and functional proteins within which cells reside
in vivo (Ravindran and George, 2014). The ECM dictates and
defines tissue/organ architecture, shape, and functionality. The
ECM is unique for each cell type and consists of a combination
of structural and functional proteins in well-defined proportions.
The exact composition of the ECM of each cell type still remains
elusive. Recent proteomic studies have shown that the ECM of
is comprised of thousands of proteins ranging from structural
proteins and growth factors to even transcription factors (Alves
et al., 2011). Several proteins believed to be intracellular in nature
are being discovered in the ECM possessing important extra-
cellular roles (Ravindran and George, 2014). We have identified
two such proteins namely; glucose regulated protein 78 (GRP78)
(Ravindran et al., 2012a) and TGFβ receptor interacting protein
1 (TRIP1) (Ramachandran et al., 2012) that possess extra-
cellular roles apart from their well-characterized intracellular
functions.
KEY CONCEPT 3 | Extracellular matrix (ECM)
The ECM is the cell-secreted environment within which cells are embed-
ded. The ECM and cells together constitute a tissue. Several tissues pos-
sess a complex architecture consisting of multiple cell types and their ECM
arranged in a defined architecture to coherently perform a function. The
three layers of an artery is a simple example. The ECM defines tissue
functionality (bone, cartilage etc.) and governs cell behavior, growth, and
differentiation.
Considering the nature and complexity of the ECM, present
strategies aimed at using a few factors seem inadequate to accom-
plish and maintain the engineered tissue. Many studies have sug-
gested the use of decellularized tissues as allografts and xenografts
(Badylak et al., 2011; Crapo et al., 2011; Sabetkish et al., 2014).
However, as the ECM for each cell type is unique, it is not a
feasible strategy to use the matrices derived from other decellu-
larized tissues for dental pulp tissue regeneration. On the other
hand, decellularized dental pulp tissues can be a viable option
if appropriate protocol to obtain them and store them in sub-
stantial quantities is available. This can be a daunting task to
accomplish. Therefore, the ideal and clinically relevant strategy
would be to recreate the dental pulp environment in vitro using
an approach that can be transitioned into a mass-producible
environment.
Use of Biomimetic Scaffolds
Our approach is focused on creating an environment that
mimics the native pulp environment to illicit an appropriate
stem cell response and behavior. We have created an ECM
based biomimetic scaffold that contains an intact ECM of
differentiating dental pulp stem cells (Ravindran et al., 2014b).
Ours and other published studies have shown the effectiveness
of ECM derived scaffolds for inducing lineage specific differen-
tiation of stem cells for several purposes including bone, carti-
lage, and vascular tissue(Bourget et al., 2012; Ravindran et al.,
2012a; Levorson et al., 2014a). However, our approach to pulp
tissue engineering is unique in that we aim to differentiate
BMSCs to a pulpal lineage using a pulp-specific ECM scaffold.
Our studies show that that this scaffold contains both structural
and functional proteins required for pulp tissue regeneration
(Figure 1) (Ravindran et al., 2014b).
KEY CONCEPT 4 | Biomimetics
With respect to the field of tissue regeneration, biomimetic refers to strategies
that aim to mimic the native biological environment. Tissues in the human bod-
ies are extremely complex entities. Their architecture and composition have
evolved over millions of years to achieve specific functions. Therefore, attempt-
ing to redesign them is a futile effort. The emerging field of biomimetics aims to
recreate the natural environment for use in regenerative medicine. In this article,
biomimetic refers to the native cell-generated pulp ECM that is incorporated
within the collagen/chitosan framework.
Advantages of Using Our Native ECM
Incorporated Biomimetic Scaffold
Collagen and chitosan constitute the base materials of this
biomimetic scaffold. These are both naturally occurring biopoly-
mers that have been shown to be biocompatible and biodegrad-
able without causing adverse immune reactions (reviewed in
George and Ravindran, 2010). Additionally, chitosan also pos-
sesses antimicrobial properties (Kim et al., 2003) that can poten-
tially prevent secondary infections during and after pulp tissue
regeneration especially after the native pulp has been under bac-
terial attack. In combination with the immunomodulatory prop-
erty of BMSCs, we can expect to have a potent system to actively
fight infection.
The ECM itself is secreted by the cells, consists of struc-
tural and functional proteins present in the pulp tissue and is
incorporated three dimensionally within the collagen/chitosan
framework. One of the salient features of the ECM is that it
presents a completely engineered pulp environment containing
physiologically relevant amounts of growth factors, cytokines,
and metalloproteases. Structural proteins such as collagen and
fibronectin can sequester the growth factors and present them
to the cells in a manner that mimics the biological scenario
in vivo.
From a translational perspective, the biomimetic scaffolds
can be mass-produced using human pulp cell lines. Published
studies have demonstrated the safety of telomerase transfected
human cell lines (Nakahara et al., 2009; Bourgine et al., 2014).
However, for the generation of ECM incorporated scaffolds, cell
lines will only be used to generate the scaffold. Patient spe-
cific somatic stem cells (DPSCs if available of BMSCs), can
then be used for regeneration. Therefore, there is little chance
of oncogenic transformation and a high potential for clinical
translation.
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FIGURE 1 | Expression of ECM proteins (Ravindran et al.,
2014b). (A–P) are representative confocal micrographs showing the
expression of various ECM proteins in the ECM scaffold sections.
Fibronectin (A) was used as a positive control and tubulin (B) was
used as a negative control for intracellular protein. DAPI staining (C)
was performed to rule out the presence of DNA material in the
ECM scaffold. (D) shows absence of rabbit and mouse non-specific
secondary antibody binding. (E–H) show the presence of growth
factors BMP2 (bone morphogenetic protein 2), TGFβ1 (transforming
growth factor β1), pro angiogenic factor VEGF, and anti angiogenic
factor PEDF (pigment epithelium derived factor), respectively. (I,J)
show the presence of matrix metalloproteases 2 and 9, respectively.
(K,L) show the presence of phosphorylated proteins in the ECM by
localizing the presence of phosphorylated serines and tyrosines.
(M–P) show the presence of non-collagenous proteins DMP1 (dentin
matrix protein 1), thrombospondin, DSP (dentin sialoprotein), and
DPP (dentin phosphophoryn). Scale bar represents 20µm in (C–E,
I, J, L). Scale bar represents 10µm in all other images.
The ECM Scaffold Can Trigger the BMSCs
to Differentiate toward an Odontogenic
Lineage
The ECM scaffolds can initiate and maintain odontogenic dif-
ferentiation in DPSCs, BMSCs, and PDLSCs without the need
for external delivery of growth factors or differentiating agents
(Ravindran et al., 2014a). Of the three cell types, BMSCs are best
suited for translation into a clinical setting owing to their ready
availability and standardized isolation technique. Figure 2 shows
the fold change in gene expression of human marrow stromal
cells (HMSCs) cultured within the ECM scaffolds with reference
to those cultured within control (non-ECM) collagen/chitosan
scaffolds. Our published data shows the behavior of DPSCs and
PDLSCs in the same environment (Ravindran et al., 2014a).
Our results indicate that the three cell types perform differently
in similar environments. However, the end result was a pro-
odontogenic differentiation as evidenced by positive regulation
of the dentin sialo phospho protein (DSPP) gene. Thus, the gene
expression profile shows the potential of the pulp ECM scaffolds
to direct odontogenic differentiation of BMSCs as well as DPSCs
and PDLSCs.
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FIGURE 2 | Quantitative real time PCR analysis. The bars
represent mean fold change in gene expression by the HMSCs
cultured within the pulp ECM scaffolds with respect to HMSCs
cultured within control collagen/chitosan scaffolds. The experiments
were performed in quadruplicates. The error bars represent
standard deviation. The statistical significance was calculated
using student’s t-test. *Represents significant change with
P < 0.05.
The potential of the pulp ECM scaffolds were also evaluated in
vivo. When implanted subcutaneously in immunocompromiced
mice, the biomimetic ECM scaffolds triggered odontogenic
differentiation of DPSCs, PDLSCs, and BMSCs (Ravindran et al.,
2014a). Figure 3 shows odontogenic differentiation of BMSCs
in vivo. BMSCs expressed the marker proteins DSP and DPP
suggesting positive differentiation toward the odontogenic lin-
eage. These experiments showed clearly that the BMSCs possess
the potential for odontogenic differentiation if they are provided
with an appropriate extracellular environment. Additionally, the
experiments also showed that the pulp ECM incorporated scaf-
folds, can trigger odontogenic differentiation of different types of
mesenchymal stem cells and that all the cell types do not follow
similar pathways to achieve lineage specific differentiation.
The Biomimetic ECM Scaffolds can Trigger
Vascularization in vivo
The data presented in Figure 1 shows that the ECM scaf-
folds, amongst other proteins, contains pro-vascular growth
factors such as vascular endothelial growth factor (VEGF). When
these scaffolds were implanted subcutaneously in nude mice,
they showed more robust vascularization compared to con-
trol scaffolds indicating their ability to promote vascularization
(Figure 4). The data presented in the figure show that the ECM
scaffolds promote vascularization in the presence of both DPSCs
and BMSCs. Our published results show vascularization in the
presence of DPSCs, BMSCs, and PDLSCs (Ravindran et al.,
2014a). The images in Figure 4 show the presence of endothe-
lial cells that stained positive for von Willebrand factor. Note
the presence of capillary-like structures in the ECM scaffold
containing BMSCs.
One of the primary challenges associated with dental pulp tis-
sue engineering is vascularization of the tissue. The apex of the
root canal space is small. It is also the only opening through
which the tissue can be vascularized. It is imperative that any
tissue engineering technology that attempts to regenerate the
dental pulp is pro-vascular in nature. Therefore, the ability of
the biomimetic ECM scaffolds to induce vascularization will be
highly beneficial toward clinical translation of this approach to
pulp tissue regeneration.
Implications of this Biomimetic Technology
on Other Fields of Tissue Engineering
In this review, we have discussed the uniqueness of cell
type—specific ECM. The generation of biomimetic scaffolds is
therefore not limited to dental pulp tissue regeneration. It can be
applied toward all fields of tissue engineering. Other groups and
us have tested this strategy for regeneration of bone (Thibault
et al., 2010; Ravindran et al., 2012a). Recently, similar strate-
gies have been attempted for generating ECM incorporated scaf-
folds for cartilage tissue regeneration (Levorson et al., 2014a,b).
Apart from being used for generating new biomaterials, this
strategy can also be used to improve the properties of existing
clinical materials. We are presently, working on improving the
Frontiers in Physiology | www.frontiersin.org 6 April 2015 | Volume 6 | Article 118
Ravindran and George Biomimetics in dental pulp regeneration
FIGURE 3 | Fluorescence Immunohistochemistry. The fluorescent
images are representative confocal micrographs of sections from HMSC
seeded scaffold explants consisting of control collagen/chitosan scaffold (A)
and pulp ECM scaffold (B). The sections were analyzed for the expression of
DMP1 (A1,B1), DSP (A2,B2), DPP (A3,B3), and VEGF (A4,B4). Note the
absence of DSP and DPP signal in (A) (control scaffolds containing HMSCs).
White arrows in (B) point to positive staining of the same by HMSCs seeded
within the pulp ECM scaffold. Yellow arrows in (B3) point to non-specific
fluorescence from red blood corpuscles (RBCs). The presence of RBCs also
indicate the presence of active capillaries. Note the increase in DMP1
(comparing images A1 and B1) and VEGF (comparing images A4 and B4)
expression. The secondary antibody control for rabbit and mouse secondary
antibodies did not show any staining (C). The imaging conditions were
maintained constant. The scale bar represents 20µm in all images.
bioactivity and regenerative capacity of existing clinical materials
such as demineralized bone matrices (DBM) using this technol-
ogy. Additionally, we are also focusing on generation of platforms
to aid transplantation surgery (such as biomimetic platforms to
enable vascularization for islet transplantation). We envision that
in the near future, several medical devices and biomaterials that
are currently in use and biologically inert, can be improved using
this biomimetic approach.
Conclusion and Future Direction
In this focused review, we have discussed the challenges facing
clinical translation of dental pulp tissue engineering approaches.
We believe that the limited availability of dental stem cells and the
limitations of growth factor delivery systems and dosage compli-
cations severely hamper the potential of current approaches. Our
experiments have demonstrated that it is possible to overcome
these hurdles by using biomimetically engineered pulp ECM
incorporated scaffolds that we have developed. These scaffolds
possess the ability to trigger lineage specific differentiation of
several mesenchymal stem cell types in vitro and in vivo. There-
fore, dental stem cells can be avoided if appropriate sources are
not available. On the other hand our experiments also show
that these scaffolds contain an array of lineage specific proteins
that include both structural and functional proteins in physio-
logically relevant quantities. Therefore, the use of these scaffolds
will overcome the need for using complex growth factor delivery
systems.
Although the results are promising, several factors need to
be standardized before this technology can be ready for clini-
cal translation. To achieve mass-production and minimal batch
variability, the ECM incorporated scaffolds need to be pro-
duced using dental stem cell lines. Standardized tests need to be
developed to assess the quality of the scaffolds and to quantita-
tively evaluate the levels of different growth factors and ECM
proteins within the scaffolds. These tests will ensure product
reliability and minimum performance thresholds. Our current
research is focused on two objectives: The first objective is to
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FIGURE 4 | von Willebrand factor (VWF) immunohistochemistry. The
micrographs are representative images of VWF stained explant sections
containing DPSCs (A1,A2) and HMSCs (B1,B2) in control and pulp ECM
scaffolds. The arrows in the images point to positively stained endothelial cells
(black arrows). Note the absence of endothelial cells in the control scaffolds
containing both DPSCs (A1) and HMSCs (B1). The scale bar in all the images
represents 20µm.
test the effectiveness of these biomimetic scaffolds in a large
animal pulpectomy model to evaluate vascularization, innerva-
tion, and overall complete regeneration of intact pulp tissue. The
second objective that we are working on is to standardize their
potential for mass production using dental pulp stem cell lines
and bioreactors. We envision that if we are able to accomplish
both of these objectives, these biomimetic ECM scaffolds have
immense potential to successfully replace root canal therapy with
a regenerative therapy that will maintain tooth vitality, function-
ality, and longevity. Results from these studies will serve as a
proof of concept for application to other fields of regenerative
medicine.
Overall, our goal is to enhance the translational potential of
tissue-engineering strategies by eliminating the need for growth
factor delivery systems and sub population of stem cells that have
limited availability. This biomimetic technology is a step in this
direction.
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